{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:29:10Z","timestamp":1786548550658,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/ajg.2015.207","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T08:01:34Z","timestamp":1437465694000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn\u2019s Disease in the United States"],"prefix":"10.14309","volume":"111","author":[{"given":"K T","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210210","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bmj.39547.603218.AE","article-title":"Medical management of Crohns disease.","volume":"336","author":"Cummings","year":"2008","journal-title":"BMJ"},{"key":"R2-6-20210210","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s10620-009-0973-3","article-title":"Demographic characteristics of hospitalized IBD patients.","volume":"54","author":"Sonnenberg","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R3-6-20210210","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1007\/s10620-012-2289-y","article-title":"Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.","volume":"57","author":"Gunnarsson","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R4-6-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ibd.21371","article-title":"Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease.","volume":"17","author":"Kappelman","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R5-6-20210210","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3748\/wjg.v17.i22.2723","article-title":"Comorbidity in inflammatory bowel disease.","volume":"17","author":"San Roman","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R6-6-20210210","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohns disease and ulcerative colitis in US children and adults.","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"key":"R7-6-20210210","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/apt.12727","article-title":"Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohns disease.","volume":"39","author":"Rubin","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-6-20210210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/JOM.0b013e318181b8ca","article-title":"The direct and indirect cost burden of Crohns disease and ulcerative colitis.","volume":"50","author":"Gibson","year":"2008","journal-title":"J Occup Environ Med"},{"key":"R9-6-20210210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/fg.2010.003566","article-title":"Evidence-based use of anti-TNF therapy in Crohns disease; where are we in 2011?","volume":"2","author":"Everett","year":"2011","journal-title":"Frontline Gastroenterol"},{"key":"R10-6-20210210","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/MIB.0000000000000061","article-title":"Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R11-6-20210210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF therapy: results from the COIN study.","volume":"63","author":"van der Valk","year":"2014","journal-title":"Gut"},{"key":"R12-6-20210210","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1572-0241.2000.02261.x","article-title":"Annual cost of care for Crohns disease: a payor perspective.","volume":"95","author":"Feagan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R13-6-20210210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jech.55.10.716","article-title":"Depression and anxiety in people with inflammatory bowel disease.","volume":"55","author":"Kurina","year":"2001","journal-title":"J Epidemiol Community Health"},{"key":"R14-6-20210210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1365-2036.2006.03146.x","article-title":"Systemic review: managing anemia in Crohns disease.","volume":"24","author":"Kulnigg","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-6-20210210","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/ibd.21488","article-title":"Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: A review. 2011.","volume":"17","author":"Park","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R16-6-20210210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","article-title":"Practice Parameters Committee of American College of Gastroenterology. Management of Crohns disease in adults.","volume":"104","author":"Lichtenstein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R17-6-20210210","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.MIB.0000441349.40193.aa","article-title":"Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease.","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R19-6-20210210","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOG.0000000000000184","article-title":"Biosimilars in inflammatory bowel disease: ready for prime time?","volume":"31","author":"Gomollon","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"R21-6-20210210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/apt.12477","article-title":"Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases.","volume":"38","author":"Rinaudo-Gaujous","year":"2013","journal-title":"Aliment Pharmacol Ther"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2015207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201601000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:28:35Z","timestamp":1786544915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201601000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2015.207","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}